| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $273.8M | $302.4M | $357.7M |
| YoY Revenue Growth % | -9.5% | -15.5% | — |
| Gross Profit | $47.6M | $53.3M | — |
| Gross Margin % | 17.4% | 17.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $14.2M | $16.7M | $26.5M |
| Operating Margin % | 5.2% | 5.5% | 7.4% |
| Net Income (GAAP) | $11.2M | $13.3M | $20.3M |
| EBITDA (Normalized) | $28.0M | $25.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $19.2M | $35.2M | $34.8M |
| Capital Expenditures (CapEx) | $17.3M | $11.5M | — |
| Free Cash Flow (FCF) | $1.9M | $23.6M | $34.8M |
| FCF Margin % | 0.7% | 7.8% | 9.7% |
| Return on Invested Capital (ROIC %) | 8.2% | 10.5% | — |
| Cash & Short-Term Equivalents | $38.1M | $41.8M | — |
| Total Debt (Short + Long Term) | $17.6M | $19.7M | — |
| Total Stockholders' Equity | $158.2M | $147.4M | — |